This Hidden Immune Signal Could Change Cancer Therapy

A tumor “don’t‑eat‑me” shield also hides pro‑immune danger signals; new antibodies that unmask this hidden cue could make cancers more vulnerable to immune attack.

Can A Single Shot Save Your Heart?

Self‑amplifying RNA boosts a heart‑healing peptide, reducing scarring and improving heart function after a heart attack in animals as a potential add‑on therapy.

A New Antibody Approach To Preventive Treatment For HIV

A dual-action HIV antibody–drug conjugate forces Env to open, then blocks it, boosting virus neutralization up to tenfold in the lab.

The Metabolic Clue To Hot Flashes And Night Sweats In Menopause

Elevated fasting insulin in midlife predicts earlier, longer hot flashes and night sweats, suggesting simple metabolic tests could help personalize and prevent menopause symptom burden.

Kennedy And Oz Address `Addiction Epidemic,’ But Policy Details Are Murky

Trump administration says it wants to tackle the “addiction epidemic.” But it’s eliminating addiction treatment resources and access to mental healthcare.

Weighing Pros And Cons Of Prostate Cancer Blood Tests

It’s important to follow guidance on prostate-specific antigen screening that maximizes benefits and minimizes potential harms such as overdiagnosis and overtreatment.

Is The Fountain Of Youth Flowing In Our Veins?

Centenarians share a distinct, youth‑like blood protein profile in immune, metabolic, and repair pathways, suggesting circulating factors may help sustain exceptional longevity.

Promises And Pitfalls Of Multi-Cancer Diagnostic Tests

For asymptomatic people without known risks, the downsides and uncertainties of multi-cancer early detection testing could outweigh potential benefits.

The Paper-Thin Implant That Listens To Your Brain Signals

A thin, wireless brain implant with 65,000+ sensors maps vision, touch, and movement from the brain’s surface, promising gentler, high‑resolution neural interfaces.

Medicare Advantage Disenrollments Are A Growing Threat To Beneficiaries

It’s unknown at this time whether additional forced disenrollment of beneficiaries will occur later this year. But it seems likely that more plans will exit the market.